Trial of An Innovative Smartphone Intervention for Smoking Cessation

Fred Hutchinson Cancer Center2,503 enrolled

Overview

The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

2,503

Conditions

Smoking

Interventions

Smartphone-delivered Intervention (SmartQuit)BEHAVIORAL

The experimental arm includes an intervention using a novel smartphone smoking cessation app.

: Smartphone-delivered Intervention (Standard of care app)BEHAVIORAL

The control intervention uses a standard of care smartphone smoking cessation app.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age 18 or older * smokes at least five cigarettes daily for at least past 12 months * wants to quit cigarette smoking in the next 30 days * if concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days * interested in learning skills to quit smoking * willing to be randomly assigned to either condition * resides in US * has at least daily access to their own personal Apple iPhone, Android, or Windows Phone * knows how to login and download a smartphone application * willing and able to read in English * not using other smoking cessation interventions (including apps or our other intervention studies). * willing to complete all three follow-up surveys * provide email, phone, and mailing address. Exclusion Criteria: * The exclusion criteria are opposite of the inclusion criteria listed above.

Locations (1)

Fred Hutchinson Cancer Research Center

Seattle, Washington, United States

Outcomes

Primary Outcomes

30-day Point Prevalence Abstinence, Complete-case

Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are excluded for the complete-case analysis. Exact 2-sided CI was based on the observed proportion of participants.

Time frame: 12 months post randomization

Secondary Outcomes

30-day Point Prevalence Abstinence, Missing=Smoking Imputation

Percentage of participants reporting no smoking in the past 30 days, 12 months post-treatment. Participants missing follow-up data are imputed as still smoking. Exact 2-sided CI was based on the observed proportion of participants.

Time frame: 12 months post randomization

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.